Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients
Description
The clinical state of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been considered a pandemic disease (COVID-19) that is rapidly spreading worldwide. Despite all global efforts, the only treatment for COVID-19 is supportive care
